Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
EPO Biosimilars - The Future of Erythropoietin Market
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Aug, 2016| No. of Pages : 45
Please make your selection :
Electronic Access - Single User License
US$ 600.00
CD-ROM Mail Delivery
US$ 700.00
Hard Copy Mail Delivery
US$ 700.00
Electronic Access - Multi-User License
US$ 1000.00
List of Figures:
Figure 3-1: Global - Population above 60 Years (Billion), 2013 & 2050
Figure 3-2: Global - Incidences of Cancer (Million), 2015 & 2025
Figure 3-3: US - Adults (30 Years or Above) Suffering from Chronic Kidney Disease (%), 2015, 2020 & 2030
Figure 5-1: Global - Protein Therapeutics vs. Pharmaceutical Market (Billion US$), 2015
Figure 5-2: Global - Protein Therapeutics Market (Billion US$), 2015 & 2022
Figure 5-3: Global - Protein Therapeutics Market by Segment (%), 2015
Figure 5-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2022
Figure 7-1: Global - Erythropoietin Market (Billion US$), 2015 & 2022
Figure 7-2: Global - Share of Biologic and Biosimilar Erythropoietin (%), 2015
Figure 7-3: Global - Forecast for Share of Biologic and Biosimilar Erythropoietin (%), 2022
Figure 8-1: Global - Biologic Erythropoietin Market (Billion US$), 2015 & 2022
Figure 8-2: Global - Biosimilar Erythropoietin Market (Million US$), 2015 & 2022
Figure 8-3: Global - Share of Therapeutic Applications of Erythropoietin (%), 2015
Figure 9-1: Global - Share of Erythropoietin Market by Geographic Regions (%), 2015
Figure 9-2: US - Erythropoietin Market (Billion US$), 2015 & 2022
Figure 9-3: Europe - Erythropoietin Market (Billion US$), 2015 & 2022
Figure 9-4: Asia-Pacific - Erythropoietin Market (Billion US$), 2015 & 2022
Figure 10-1: Global - Erythropoietin Pipeline Analysis by Type (%), 2015
Figure 10-2: Global - Erythropoietin Pipeline Analysis by Phase (%), 2015
Figure 11-1: Global - Share of Key Players in Erythropoietin Market (%), 2015
List of Tables:
Table 8-1: Global - Biologic Erythropoietin Drugs and Their Sales
Table 10-1: Global - Erythropoietin Product Pipeline
Table 11-1: Amgen Inc. - Total Company Revenue (Billion US$), 2013, 2014 & 2015
Table 11-2: Amgen Inc. - Commercialized Erythropoietin Products
Table 11-3: Amgen Inc. - Erythropoietin Product Sales (Billion US$), 2013, 2014 & 2015
Table 11-4: Johnson & Johnson - Total Company Sales (Billion US$), 2013, 2014 & 2015
Table 11-5: Johnson & Johnson - Commercialized Erythropoietin Products
Table 11-6: Johnson & Johnson - Erythropoietin Product Sales (Billion US$), 2013, 2014 & 2015
Table 11-7: Roche - Total Company Revenue (Billion US$), 2013, 2014 & 2015
Table 11-8: Roche - Commercialized Erythropoietin Products
Table 11-9: Roche - Erythropoietin Product Sales (Billion US$), 2013, 2014 & 2015
Table 11-10: Pfizer Inc. - Total Company Revenue (Billion US$), 2013, 2014 & 2015
Table 11-11: Pfizer Inc. - Commercialized Erythropoietin Products
Table 11-12: Novartis - Total Company Sales (Billion US$), 2013, 2014 & 2015
Table 11-13: Novartis - Commercialized Erythropoietin Products
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact